+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Public hospital-based laboratory experience during an outbreak of pandemic influenza A (H1N1) virus infections



Public hospital-based laboratory experience during an outbreak of pandemic influenza A (H1N1) virus infections



Journal of Clinical Microbiology 48(4): 1189-1194



The experience of a public hospital virology laboratory during a springtime 2009 outbreak of a novel influenza A (H1N1) virus in New York State is described. Influenza virus was isolated from 145 of 613 respiratory swab specimens. Symptoms of fever (temperature, 102.7 +/- 0.32 degrees F), cough, upper respiratory infection, myalgia, and headache were reported. Atypical symptoms of nausea/vomiting and diarrhea were also observed. Illness occurred mainly in patients or=65 years old. Compared to the results of traditional culture methods, the sensitivities of a rapid chromatographic influenza A and B virus immunoassay and rapid shell vial culture were 70.3% and 98.6%, respectively. A sensitivity of 80% was obtained by testing 50 specimens by a direct fluorescent-antibody (DFA) assay. The observation of adequate numbers of cells on the DFA assay slides suggests that the low sensitivity of the chromatographic immunoassay may result from its intrinsic nature and not from improper specimen collection. A reverse transcription-PCR (RT-PCR) assay of 45 specimens performed off-site yielded 21 novel (H1N1) viruses and 2 seasonal (H3N2) influenza viruses. The mean time interval of 5.69 +/- 0.37 days from specimen collection to the availability of RT-PCR results limited the value of this assay for patient care. In laboratories lacking on-site molecular capabilities, shell vial techniques can rapidly (about 1 day) confirm negative results and/or identify false-negative chromatographic immunoassay results. Laboratories lacking culture capabilities may also use the DFA assay to confirm or replace the results obtained by these immunoassays. Increasing testing demands caused shortages in commodities and personnel. Alternative testing strategies and planning are necessary in order to optimize virus detection and ensure appropriate resource allocation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055284207

Download citation: RISBibTeXText

PMID: 20147645

DOI: 10.1128/jcm.01657-09


Related references

Investigation of an outbreak of 2009 pandemic influenza A virus (H1N1) infections among healthcare personnel in a Chicago hospital. Infection Control and Hospital Epidemiology 32(6): 611-615, 2011

Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study. Vaccine 29(45): 7975-7981, 2011

Infections with A(H1N1)2009 influenza virus in Poland during the last pandemic: experience of the National Influenza Center. Advances in Experimental Medicine and Biology 756: 271-283, 2013

Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virus. Clinical and Vaccine Immunology 21(5): 737-746, 2014

Prior infections with seasonal influenza A/H1N1 virus reduced the illness severity and epidemic intensity of pandemic H1N1 influenza in healthy adults. Clinical Infectious Diseases 54(3): 311-317, 2012

Influenza-like illness in a community surrounding a school-based outbreak of 2009 pandemic influenza A (H1N1) virus-Chicago, Illinois, 2009. Clinical Infectious Diseases 52(Suppl. 1): S94, 2011

Non-pharmaceutical interventions during an outbreak of 2009 pandemic influenza A (H1N1) virus infection at a large public university, April-May 2009. Clinical Infectious Diseases 52(Suppl. 1): S138-S145, 2011

An outbreak of influenza A (H1N1) virus in a remote Aboriginal community post-pandemic: implications for pandemic planning and health service policy. Australian and new Zealand Journal of Public Health 39(1): 15-20, 2015

The 2009 pandemic influenza A (H1N1) virus infection: experience of a paediatric service at a third-level hospital in Lisbon, Portugal. Revista Portuguesa de Pneumologia 18(4): 175-181, 2012

Pandemic vaccination strategies and influenza severe outcomes during the influenza A(H1N1)pdm09 pandemic and the post-pandemic influenza season: the Nordic experience. Euro Surveillance 21(16):, 2016

Outbreak of influenza pandemic virus A(H1N1) 2009 infections in Emergency Department, Saint-Pierre, Reunion Island. July-August 2009. Presse Medicale 39(7-8): E147-E157, 2010

Outbreak of influenza pandemic virus A(H1N1) 2009 infections in the Emergency Department, Saint-Pierre, Réunion Island, July-September 2009. Bulletin de la Societe de Pathologie Exotique 104(2): 125-134, 2011

Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory‐confirmed secondary attack rates and evidence of asymptomatic infections. Clinical Infectious Diseases 51(9): 1033-1041, 2010

Atypical influenza A(H1N1)pdm09 strains caused an influenza virus outbreak in Saudi Arabia during the 2009-2011 pandemic season. Journal of Infection and Public Health 2019, 2019

Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model. Journal of Infectious Diseases 202(7): 1011-1020, 2010